2015 -- S 0507

========

LC001264

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2015

____________

A N   A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT

     Introduced By: Senators Walaska, Felag, and Ciccone

     Date Introduced: February 26, 2015

     Referred To: Senate Judiciary

     It is enacted by the General Assembly as follows:

     SECTION 1. Section 21-28-2.08 of the General Laws in Chapter 21-28 entitled "Uniform

Controlled Substances Act" is hereby amended to read as follows:

     21-28-2.08. Contents of schedules. -- Schedule I

      (a) Schedule I shall consist of the drugs and other substances, by whatever official name,

common or usual name, chemical name, or brand name designated, listed in this section.

      (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of

the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

specific chemical designation:

      (1) Acetylmethadol

      (2) Allylprodine

      (3) Alphacetylmethadol

      (4) Alphameprodine

      (5) Alphamethadol

      (6) Benzethidine

      (7) Betacetylmethadol

      (8) Betameprodine

      (9) Betamethadol

      (10) Betaprodine

      (11) Clonitazene

      (12) Dextromoramide

      (13) Difenoxin

      (14) Diampromide

      (15) Diethylthiambutene

      (16) Dimenoxadol

      (17) Dimepheptanol

      (18) Dimethylthiambutene

      (19) Dioxaphetyl butyrate

      (20) Dipipanone

      (21) Ethylmethylthiambutene

      (22) Etonitazene

      (23) Extoxerdine

      (24) Furethidine

      (25) Hydroxypethidine

      (26) Ketobemidone

      (27) Levomoramide

      (28) Levophenacylmorphan

      (29) Morpheridine

      (30) Noracymethadol

      (31) Norlevorphanol

      (32) Normethadone

      (33) Norpipanone

      (34) Phenadoxone

      (35) Phenampromide

      (36) Phenomorphan

      (37) Phenoperidine

      (38) Piritramide

      (39) Proheptazine

      (40) Properidine

      (41) Propiram

      (42) Racemoramide

      (43) Trimeperidone

      (44) Tilidine

LC001264 - Page 2 of 20

      (45) Alpha-methylfentanyl

      (46) Beta-hydroxy-3-methylfentanyl other names:

      N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide

      (c) Opium Derivatives. - Unless specifically excepted or unless listed in another

schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever

the existence of the salts, isomers, and salts of isomers is possible within the specific chemical

designation:

      (1) Acetorphine

      (2) Acetyldihydrocodeine

      (3) Benzylmorphine

      (4) Codeine methylbromide

      (5) Codeine-N-Oxide

      (6) Cyprenorphine

      (7) Desomorphine

      (8) Dihydromorphine

      (9) Etorphine (Except hydrochloride salt)

      (10) Heroin

      (11) Hydromorphinol

      (12) Methyldesorphine

      (13) Methylihydromorphine

      (14) Morphine methylbromide

      (15) Morphine methylsulfonate

      (16) Morphine-N-Oxide

      (17) Myrophine

      (18) Nococodeine

      (19) Nicomorphine

      (20) Normorphine

      (21) Pholcodine

      (22) Thebacon

      (23) Drotebanol

      (d) Hallucinogenic Substances. - Unless specifically excepted or unless listed in another

schedule, any material, compound, mixture, or preparation that contains any quantity of the

following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers

whenever the existence of the salts, isomers, and salts of isomers is possible within the specific

LC001264 - Page 3 of 20

chemical designation (for purposes of this subsection only, the term "isomer" includes the optical,

position, and geometric isomers):

      (1) 3, 4-methylenedioxy amphetamine

      (2) 5-methoxy-3, 4-methylenedioxy amphetamine

      (3) 3, 4, 5-trimethoxy amphetamine

      (4) Bufotenine

      (5) Diethyltryptamine

      (6) Dimethyltryptamine

      (7) 4-methyl 2, 5-dimethoxyamphetamine

      (8) Ibogaine

      (9) Lysergic acid diethylamide

      (10) Marihuana

      (11) Mescaline

      (12) Peyote. Meaning all parts of the plant presently classified botanically as

Lophophora Williamsii Lemair whether growing or not; the seeds of the plant; any extract from

any part of the plant; and any compound, manufacture, salt, derivative, mixture, or preparation of

the plant, its seeds or extracts.

      (13) N-ethyl-3-piperidyl benzilate

      (14) N-methyl-3-piperidyl benzilate

      (15) Psilocybin

      (16) Psilocyn

      (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the

plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and

their isomers with similar chemical structure and pharmacological activity such as the following:

delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans

tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and

their optical isomer. (Since nomenclature of these substances is not internationally standardized,

compounds of these structures, regardless of numerical designation of atomic positions covered).

      (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2-

Thienyl analog of phencyclidine: TPCP

      (19) 2,5 dimethoxyamphetamine

      (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha-

methylphenethyamine: 4-bromo-2,5-DMA

      (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine:

LC001264 - Page 4 of 20

paramethoxyamphetamine: PMA

      (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1-

phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE

      (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP

      (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-

6,6,9-trimethyl-6H-dibenz o (b,d) pyran: Synhexyl.

      (25) Salvia Divinorum (Salvinorin A or Divinorin A), meaning any extract from any part

of the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall

not mean the unaltered plant.

      (26) Datura stamonium (jimsom weed or datura), meaning any extract from any part of

the plant, and any compound, salt derivative, or mixture of the plant or its extracts. This shall not

mean the unaltered plant.

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

material, compound, mixture, or preparation that contains any quantity of the following

substances having a depressant effect on the central nervous system, including its salts, isomers,

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

within the specific chemical designation:

      (1) Mecloqualone.

      (2) Methaqualone.

      (3) 3-methyl fentanyl (n-( ethyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide.

      (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional, and

geometric isomers, salts, and salts of isomers.

      (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts, and

salts of isomers.

      (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts,

and salts of isomers.

      (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha-

methylfentanyl), its optical isomers, salts, and salts of isomers.

      (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha-

methylthiofentanyl), its optical isomers, salts, and salts of isomers.

      (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers,

salts, and salts of isomers.

      (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta-

hydroxyfentanyl), its optical isomers, salts, and salts of isomers.

LC001264 - Page 5 of 20

      (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta-

hydroxy-3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers.

      (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3-

methylthiofentanyl), its optical and geometric isomers, salts, and salts of isomers.

      (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its

optical isomers, salts, and salts of isomers.

      (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical

isomers, salts, and salts of isomers.

      (15) N-[1-(2-phenylethyl)-4-piperidyl]N-(4-fluorophenyl)-propanamid e (para-

fluorofentanyl), its optical isomers, salts, and salts of isomers.

      (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or

geometric isomers, salts, and salts of isomers.

      (f) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

material, compound, mixture, or preparation that contains any quantity of the following

substances having a stimulant effect on the central nervous system, including its salts, isomers,

and salts of isomers:

      (1) Fenethylline

      (2) N-ethylamphetamine

      (3) 4-methyl-N-methylcathinone (Other name: mephedrone)

      (4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone)

      (5) 3,4-methylenedioxypyrovalerone (Other name: MDPV)

      (g) Any material, compound, mixture, or preparation that contains any quantity of the

following substances:

      (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol (CP-47,497)

      (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol

(cannabicyclohexanol and CP-47,497 c8 homologue)

      (3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073)

      (4) 1-[2-(4-Morpholinyl)ethyl]3-(1-naphthoyl)indole (JWH-200)

      (5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678)

      (h) Synthetic cannabinoids or piperazines. - Unless specifically excepted, any chemical

compound which is not approved by the United States Food and Drug Administration or, if

approved, which is not dispensed or possessed in accordance with state and federal law, that

contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine (TFMPP); 1,1-

Dimethylheptyl-11-hydroxytetrahydrocannabinol (HU-210); 1-Butyl-3-(1-naphthoyl) indole; 1-

LC001264 - Page 6 of 20

Pentyl-3-(1-naphthoyl) indole; dexanabinol (HU-211); or any compound in the following

structural classes:

      (1) Naphthoylindoles: Any compound containing a 3-(1-naphthoyl)indole structure with

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

group, whether or not further substituted in the indole ring to any extent and whether or not

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

limited, to JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, and AM-

2201;

      (2) Phenylacetylindoles: Any compound containing a 3-phenylacetylindole structure

with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

group whether or not further substituted in the indole ring to any extent and whether or not

substituted in the phenyl ring to any extent. Examples of this structural class include, but are not

limited to, JWH-167, JWH-250, JWH-251, and RCS-8;

      (3) Benzoylindoles: Any compound containing a 3-(benzoyl) indole structure with

substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

group whether or not further substituted in the indole ring to any extent and whether or not

substituted in the phenyl ring to any extent. Examples of this structural class include, but are not

limited, to AM-630, AM-2233, AM-694, Pravadoline (WIN 48,098), and RCS-4;

      (4) Cyclohexylphenols: Any compound containing a 2-(3-hydroxycyclohexyl)phenol

structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

group whether or not substituted in the cyclohexyl ring to any extent. Examples of this structural

class include, but are not limited to, CP 47,497 and its C8 homologue (cannabicyclohexanol);

      (5) Naphthylmethylindoles: Any compound containing a 1H-indol-3-yl-(1-naphthyl)

methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl,

alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-

morpholinyl)ethyl group whether or not further substituted in the indole ring to any extent and

whether or not substituted in the naphthyl ring to any extent. Examples of this structural class

include, but are not limited to, JWH-175, JWH-184, and JWH-185;

      (6) Naphthoylpyrroles: Any compound containing a 3-(1-naphthoyl)pyrrole structure

with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl,

LC001264 - Page 7 of 20

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

group whether or not further substituted in the pyrrole ring to any extent and whether or not

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

limited, to JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;

      (7) Naphthylmethylindenes: Any compound containing a 1-(1-naphthylmethyl)indene

structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl,

cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl

group whether or not further substituted in the indene ring to any extent and whether or not

substituted in the naphthyl ring to any extent. Examples of this structural class include, but are not

limited to, JWH-176; or

      (8) Any other synthetic cannabinoid or piperazine which is not approved by the United

States Food and Drug Administration or, if approved, which is not dispensed or possessed in

accordance with state and federal law;

      (i) Synthetic cathinones. - Unless specifically excepted, any chemical compound which

is not approved by the United States Food and Drug Administration or, if approved, which is not

dispensed or possessed in accordance with state and federal law, not including bupropion,

structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either

phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in

one or more of the following ways:

      (1) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy,

haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system

by one or more other univalent substituents. Examples of this class include, but are not limited to,

3,4-Methylenedioxycathinone (bk-MDA);

      (2) By substitution at the 3-position with an acyclic alkyl substituent. Examples of this

class include, but are not limited to, 2-methylamino-1-phenylbutan-1-one (buphedrone);

      (3) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or

methoxybenzyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.

Examples of this class include, but are not limited to, Dimethylcathinone, Ethcathinone, and

α-Pyrrolidinopropiophenone (α-PPP); or

      (4) Any other synthetic cathinone which is not approved by the United States Food and

Drug Administration or, if approved, is not dispensed or possessed in accordance with state or

federal law;

     (5) Any synthetic cannabinoid or cathinone not regulated by the federal Food and Drug

Administration, or by state law that binds to the cannabinoid receptor(s) and/or mimics the

LC001264 - Page 8 of 20

pharmacological response of a schedule I or II controlled substance as determined by the process

described in § 21-28-7.0 shall be considered a schedule I substance.

      Schedule II

      (a) Schedule II shall consist of the drugs and other substances, by whatever official

name, common or usual name, chemical name, or brand name designated, listed in this section.

      (b) Substances, vegetable origin, or chemical synthesis. - Unless specifically excepted or

unless listed in another schedule, any of the following substances whether produced directly or

indirectly by extraction from substances of vegetable origin, or independently by means of

chemical synthesis, or by a combination of extraction and chemical synthesis:

      (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or

opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the

following:

      (i) Raw opium

      (ii) Opium extracts

      (iii) Opium fluid extracts

      (iv) Powdered opium

      (v) Granulated opium

      (vi) Tincture of opium

      (vii) Etorphine hydrochloride

      (viii) Codeine

      (ix) Ethylmorphine

      (x) Hydrocodone

      (xi) Hydromorphone

      (xii) Metopon

      (xiii) Morphine

      (xiv) Oxycodone

      (xv) Oxymorphone

      (xvi) Thebaine

      (2) Any salt, compound, derivative, or preparation that is chemically equivalent or

identical with any of the substances referred to in subdivision (1) of this subsection, except that

these substances shall not include the isoquinoline alkaloids of opium.

      (3) Opium poppy and poppy straw.

      (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and

any salt, compound, derivative, or preparation that is chemically equivalent or identical with any

LC001264 - Page 9 of 20

of these substances, except that the substances shall not include decocainized coca leaves or

extraction of coca leaves, which extractions do not contain cocaine or ecgonine.

      (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or

powder form that contains the phenanthrine alkaloids of the opium poppy).

      (c) Opiates. - Unless specifically excepted or unless listed in another schedule, any of the

following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters, and

ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the

specific chemical designation:

      (1) Alphaprodine

      (2) Anileridine

      (3) Bezitramide

      (4) Dihydrocodeine

      (5) Diphenoxylate

      (6) Fentanyl

      (7) Isomethadone

      (8) Levomethorphan

      (9) Levorphanol

      (10) Metazocine

      (11) Methadone

      (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

      (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic

acid

      (14) Pethidine

      (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

      (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

      (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

      (18) Phenaxocine

      (19) Piminodine

      (20) Racemethorphan

      (21) Racemorphan

      (22) Bulk Dextropropoxyphene (non-dosage forms)

      (23) Suffentanil

      (24) Alfentanil

      (25) Levoalphacetylmethadol

LC001264 - Page 10 of 20

      (d) Stimulants. - Unless specifically excepted or unless listed in another schedule, any

material, compound, mixture, or preparation that contains any quantity of the following

substances having a stimulant effect on the central nervous system:

      (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.

      (2) Methamphetamine, its salts, and salts of its isomers.

      (3) Phenmetrazine and its salts.

      (4) Methylphenidate.

      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any

material, compound, mixture, or preparation that contains any quantity of the following

substances having a depressant effect on the central nervous system, including its salts, isomers,

and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible

within the specific chemical designation:

      (1) Amobarbital

      (2) Glutethimide

      (3) Methyprylon

      (4) Pentobarbital

      (5) Phencyclidine

      (6) Secobarbital

      (7) Phencyclidine immediate precursors:

      (i) 1-phencyclohexylamine

      (ii) 1-piperidinocyclohexane-carbonitrile (PCC)

      (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some

other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone.

      Schedule III

      (a) Unless specifically excepted or unless listed in another schedule, any material,

compound, mixture, or preparation that contains any quantity of the following substances having

a depressant effect on the central nervous system:

      (1) Any substance that contains any quantity of a derivative of barbituric acid or any salt

of a derivative of barbituric acid.

      (2) Chlorhexadol

      (3) Lysergic acid

      (4) Lysergic acid amide

      (5) Sulfondiethylmethane

      (6) Sulfonethylmethane

LC001264 - Page 11 of 20

      (7) Sylfonmethane

      (8) Any compound, mixture, or preparation containing amobarbital, secobarbital,

pentobarbital, or any salt of them and one or more other active medicinal ingredients that are not

listed in any schedule.

      (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or

any salt of any of these drugs and approved by the Food and Drug Administration for marketing

only as a suppository.

      (10) Ketamine, its salts, isomers, and salts of isomers. (Some other names for ketamine:

(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone).

      (b) Unless specifically excepted or unless listed in another schedule, any material,

compound, mixture, or preparation containing limited quantities of any of the following narcotic

drugs, or any salts of them:

      (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal

or greater quantity of an isoquinoline alkaloid of opium.

      (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred

milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or

more active, nonnarcotic ingredients in recognized therapeutic amounts.

      (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

a fourfold or greater quantity of an isoquinoline alkaloid of opium.

      (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

      (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one

hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

      (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one

hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with

one or more active nonnarcotic ingredients in recognized therapeutic amounts.

      (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred

milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five

milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in

recognized therapeutic amounts.

LC001264 - Page 12 of 20

      (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters

(100 mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in

recognized therapeutic amounts.

      (c) Stimulants. - Unless specifically excepted or listed in another schedule, any material,

compound, mixture, or preparation that contains any quantity of the following substances having

a stimulant effect on the central nervous system, including its salts, isomers, and salts of the

isomers whenever the existence of the salts of isomers is possible within the specific chemical

designation:

      (1) Benzphetamine

      (2) Chlorphentermine

      (3) Clortermine

      (4) Mazindol

      (5) Phendimetrazine

      (d) Steroids and hormones. - Anabolic steroids (AS) or human growth hormone (HGH),

excluding those compounds, mixtures, or preparations containing an anabolic steroid that because

of its concentration, preparation, mixture, or delivery system, has no significant potential for

abuse, as published in 21 CFR 1308.34, including, but not limited to, the following:

      (1) Chlorionic gonadotropin

      (2) Clostebol

      (3) Dehydrochlormethyltestosterone

      (4) Ethylestrenol

      (5) Fluoxymesterone

      (6) Mesterolone

      (7) Metenolone

      (8) Methandienone

      (9) Methandrostenolone

      (10) Methyltestosterone

      (11) Nandrolone decanoate

      (12) Nandrolone phenpropionate

      (13) Norethandrolone

      (14) Oxandrolone

      (15) Oxymesterone

      (16) Oxymetholone

      (17) Stanozolol

LC001264 - Page 13 of 20

      (18) Testosterone propionate

      (19) Testosterone-like related compounds

      (20) Human Growth Hormone (HGH)

      (e) Hallucinogenic substances.

      (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in

U.S. Food and Drug Administration-approved drug product. (Some other names for dronabinol:

(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d]yra n-1-ol,or(-)-

delta-9(trans)-tetrahydrocannabinol.)

      Schedule IV

      (1) Barbital.

      (2) Chloral betaine

      (3) Chloral hydrate

      (4) Ethchrovynol

      (5) Ethinamate

      (6) Methohexital

      (7) Meprobamate

      (8) Methylphenobarbital

      (9) Paraldehyde

      (10) Petrichloral

      (11) Phenobarbital

      (12) Fenfluramine

      (13) Diethylpropion

      (14) Phentermine

      (15) Pemoline (including organometallic complexes and chelates thereof).

      (16) Chlordiazepoxide

      (17) Clonazepam

      (18) Clorazepate

      (19) Diazepam

      (20) Flurazepam

      (21) Mebutamate

      (22) Oxazepam

      (23) Unless specifically excepted or unless listed in another schedule, any material,

compound, mixture, or preparation that contains any quantity of the following substances,

including its salts:

LC001264 - Page 14 of 20

      Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2-

propronoxybutane).

      (24) Prazepam

      (25) Lorazepam

      (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25)

micrograms of atropine sulfate per dosage unit.

      (27) Pentazocine

      (28) Pipradrol

      (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane

      (30) Temazepam

      (31) Halazepam

      (32) Alprazolam

      (33) Bromazepam

      (34) Camazepam

      (35) Clobazam

      (36) Clotiazepam

      (37) Cloxazolam

      (38) Delorazepam

      (39) Estazolam

      (40) Ethyl Ioflazepate

      (41) Fludizaepam

      (42) Flunitrazepam

      (43) Haloxazolam

      (44) Ketazolam

      (45) Loprazolam

      (46) Lormetazepam

      (47) Medazepam

      (48) Nimetazepam

      (49) Nitrazepam

      (50) Nordiazepam

      (51) Oxazolam

      (52) Pinazepam

      (53) Tetrazepam

      (54) Mazindol

LC001264 - Page 15 of 20

      (55) Triazolam

      (56) Midazolam

      (57) Quazepam

      (58) Butorphanol

      (59) Sibutramine

      Schedule V

      (a) Any compound, mixture, or preparation containing any of the following limited

quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal

ingredients in sufficient proportion to confer upon the compound, mixture, or preparation

valuable medicinal qualities other than those possessed by the narcotic drug alone:

      (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100

mls.) or per one hundred grams (100 gms.).

      (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100

milliliters (100 mls.) or per one hundred grams (100 gms.).

      (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100

milliliters (100 mls.) or per one hundred grams (100 gms.).

      (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less

than twenty-five (25) micrograms of atropine sulfate per dosage unit.

      (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred

milliliters (100 mls.) or per one hundred grams (100 gms.).

      (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than

twenty-five (25) micrograms of atropine sulfate per dosage unit.

      (c) Buprenorphine

      (d) Unless specifically exempted or excluded or unless listed in another schedule, any

material, compound, mixture, or preparation that contains any quantity of the following

substances having a stimulant effect on the central nervous system, including its salts, isomers,

and salts of isomers:

      (1) Propylhexedrine (except as benzedrex inhaler)

      (2) Pyrovalerone.

     SECTION 2. Chapter 21-28 of the General Laws entitled "Uniform Controlled

Substances Act" is hereby amended by adding thereto the following section:

     21-28-7.0. New synthetic drug enforcement. – (a) Legislative intent. The legislature

recognizes the recent growth of synthetic drugs, including, but not limited to, spice/k2 and bath

salts, and the dangers caused by these substances. The concern is exemplified by a Substance

LC001264 - Page 16 of 20

Abuse and Mental Health Services Administration report which summarizes the frequency and

trends of abuse for these substances. The legislature further recognizes that better methods and

strategies that appropriately respond to new synthetic drugs as soon as they are made known to

the state is of particular importance. The legislature further recognizes that law enforcement is in

need of presumptive testing tools capable of quickly identifying substances as illegal synthetic

drugs defined under state law. It is the intent of this legislation to create a process where

synthetic drugs can be quickly outlawed under state law and instantly identified by police in the

field.

     (b) Synthetic cannabinoid or cathinone as a schedule I narcotic. Pursuant to § 21-28-

2.08(i)(5):

     (1) Any synthetic cannabinoid or cathinone not regulated by the federal Food and Drug

Administration, or by state law that binds to the cannabinoid receptor(s) and/or mimics the

pharmacological response of a schedule I or II controlled substance shall be considered a

schedule I substance pursuant to § 21-28-2.08.

     (c) Nothing in this section shall interfere with the exemptions provided for under state

law to any person or entity that possesses a chemical formula defined as a scheduled drug for any

lawful purposes.

     (d) In determining whether a synthetic or cathinone not regulated by the Federal Food

and Drug Administration, or by state law binds to cannabinoid receptor(s) and/or mimics a

pharmacological response required pursuant to § 21-28-7.0(b) the following process shall be

followed:

     (1) At least every ninety (90) days, and in consultation with the state police forensic

department, the board of pharmacy shall send official correspondence to the governor, attorney

general and legislature outlining whether the board has identified any new chemical formulas that

are used to make synthetic cannabinoids or cathinones (synthetic drugs) that are not currently

illegal under state law. To identify new chemical formulas, the board shall, among other

activities, routinely communicate with state police forensic department, the United States Drug

Enforcement Agency, the United States Office of National Drug Control Policy, and the

Scientific Working Group for the Analysis of Seized Drugs (SWDRUG), and other state boards

of pharmacy.

     (2) If the board's official correspondence to the governor, attorney general and legislature

confirms that the board has identified new chemical formulas that are used to make synthetic

drugs, the board shall immediately propose an emergency rule to determine and add any new

chemical formulas to the current list of chemical formulas that are listed in state statute as

LC001264 - Page 17 of 20

scheduled drugs, and vote on the proposed rule as quickly as allowed for under the board's notice

and public comment rules. If the board votes to adopt the emergency rule under this subsection,

the rule shall take effect immediately pursuant to this section, and the new rule will be recognized

as law under the state scheduled drug statute.

     (3) Any emergency rules created under this section will automatically sunset in twelve

(12) months from the date that the emergency rule becomes effective.

     (4) Nothing in this section shall interfere with the exemptions provided for under state

law to any person or entity that possesses a chemical formula defined as a scheduled drug for any

lawful purposes.

     (e) Law enforcement field testing to instantly identify synthetic drugs. (1) The Rhode

Island state police in conjunction with the attorney general's office shall create a pilot program

that uses technologies and protocols to instantly identify synthetic cannabinoids and cathinones

(synthetic drugs), as well as other designer drugs. The pilot program shall focus on using

technology capable of presumptive identification of illicit drugs in the field.

     (2) The Rhode Island state police and/or the attorney general's office may choose to have

one or more of the pilot program sites located within a city or town police department.

     (3) Prior to July 30, 2016, the agency shall submit a report to the general assembly

outlining the findings of the pilot program, and make any recommendation on whether the

technologies and protocols selected for the pilot program can be used to help prevent the growth

of synthetic drugs and other illicit drugs throughout the state. Specifically, the evaluation shall

include, but not limited to the following:

     (i) Review of technical capabilities and accuracy rates of technologies and protocols

selected for the pilot program.

     (ii) Describe the impact to state and local crime lab backlogs if the technologies and

protocols selected could eliminate the need to send synthetic drugs, or other illicit drugs to the

crime lab for presumptive testing, including the potential cost savings to state and local

government.

     (iii) Describe the status of courts acceptance of the technologies and protocols selected

for the pilot program for the presumptive identification of synthetic drugs and other illicit drugs.

     (f) The superintendent of the state police and/or the attorney general are authorized to

promulgate rules and regulations necessary to implement the provisions of this section.

     (g) Severability. If any provision of this section or the application thereof to any person

or circumstances is held invalid, such invalidity shall not affect other provisions or applications of

the section, which can be given effect without the invalid provision or application, and to this end

LC001264 - Page 18 of 20

the provisions of this section are declared to be severable.

     SECTION 3. This act shall take effect upon passage.

========

LC001264

========

LC001264 - Page 19 of 20

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT

***

     This act would create a process for the state police and attorney general to identify and

make illegal as schedule I controlled substances certain synthetic substances/compounds which

are currently unregulated.

     This act would take effect upon passage.

========

LC001264

========

LC001264 - Page 20 of 20